TTNP is ready to explode.
Priority Review NDA filed for the huge addiction market.
Millions upon millions are addicted to pain meds and illicit drugs.
TTNP has a 6 month slow release abuse proof medication.
Its patented ProNeura technology is also being advanced for chronic pain and Parkinson's.
A Big Pharma partnership is targeted for December.
AbbVie, the Abbott Labs spinoff, is the rumored suitor.
1 share of FB gets you 28 shares of TTNP.
FB has had its run, TTNP's is just starting.
You are spot on.
I own over 1 million shares of TTNP.
It's an undiscovered, undervalued biotech.
An NDA drug for a huge market is worth 5X the current market cap.
How many shares do you have, Jenn?